200 related articles for article (PubMed ID: 35180460)
1. Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients.
Kaur S; Singh A; Kaur J; Verma N; Pandey AK; Das S; Bhattacharyya S; Guchhait P
Blood Cells Mol Dis; 2022 May; 94():102653. PubMed ID: 35180460
[TBL] [Abstract][Full Text] [Related]
2. Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia.
Taus F; Salvagno G; Canè S; Fava C; Mazzaferri F; Carrara E; Petrova V; Barouni RM; Dima F; Dalbeni A; Romano S; Poli G; Benati M; De Nitto S; Mansueto G; Iezzi M; Tacconelli E; Lippi G; Bronte V; Minuz P
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2975-2989. PubMed ID: 33052054
[TBL] [Abstract][Full Text] [Related]
3. Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19.
Hottz ED; Martins-Gonçalves R; Palhinha L; Azevedo-Quintanilha IG; de Campos MM; Sacramento CQ; Temerozo JR; Soares VC; Dias SSG; Teixeira L; Castro Í; Righy C; Souza TML; Kurtz P; Andrade BB; Nakaya HI; Monteiro RQ; Bozza FA; Bozza PT
Blood Adv; 2022 Sep; 6(17):5085-5099. PubMed ID: 35420680
[TBL] [Abstract][Full Text] [Related]
4. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
Barale C; Melchionda E; Morotti A; Russo I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
[TBL] [Abstract][Full Text] [Related]
5. Platelet gene expression and function in patients with COVID-19.
Manne BK; Denorme F; Middleton EA; Portier I; Rowley JW; Stubben C; Petrey AC; Tolley ND; Guo L; Cody M; Weyrich AS; Yost CC; Rondina MT; Campbell RA
Blood; 2020 Sep; 136(11):1317-1329. PubMed ID: 32573711
[TBL] [Abstract][Full Text] [Related]
6. Platelet activity and hypercoagulation in type 2 diabetes.
Pretorius L; Thomson GJA; Adams RCM; Nell TA; Laubscher WA; Pretorius E
Cardiovasc Diabetol; 2018 Nov; 17(1):141. PubMed ID: 30388964
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
8. Antibody-induced procoagulant platelets in severe COVID-19 infection.
Althaus K; Marini I; Zlamal J; Pelzl L; Singh A; Häberle H; Mehrländer M; Hammer S; Schulze H; Bitzer M; Malek N; Rath D; Bösmüller H; Nieswandt B; Gawaz M; Bakchoul T; Rosenberger P
Blood; 2021 Feb; 137(8):1061-1071. PubMed ID: 33512415
[TBL] [Abstract][Full Text] [Related]
9. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
[TBL] [Abstract][Full Text] [Related]
11. Platelets and COVID-19.
Rohlfing AK; Rath D; Geisler T; Gawaz M
Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
[TBL] [Abstract][Full Text] [Related]
12. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.
Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292
[TBL] [Abstract][Full Text] [Related]
13. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond.
Sciaudone A; Corkrey H; Humphries F; Koupenova M
Circ Res; 2023 May; 132(10):1272-1289. PubMed ID: 37167360
[TBL] [Abstract][Full Text] [Related]
14. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
15. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
Salamanna F; Maglio M; Landini MP; Fini M
Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
[TBL] [Abstract][Full Text] [Related]
16. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
17. Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.
Jakobs K; Reinshagen L; Puccini M; Friebel J; Wilde AB; Alsheik A; Rroku A; Landmesser U; Haghikia A; Kränkel N; Rauch-Kröhnert U
Front Immunol; 2022; 13():844701. PubMed ID: 35359931
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
19. Alterations in platelets during SARS-CoV-2 infection.
Brambilla M; Canzano P; Becchetti A; Tremoli E; Camera M
Platelets; 2022 Feb; 33(2):192-199. PubMed ID: 34384321
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
